| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
-42,997 | -36,147 | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
1,330 | 1,237 | |||||
Stock-based compensation expense | ||||||
2,051 | 1,170 | |||||
Loss (gain) on disposal of capital equipment | ||||||
35 | -17 | |||||
Gain on foreign currency translation | ||||||
-24 | 0 | |||||
Other noncash income (loss), net | ||||||
-20 | 14 | |||||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other long-term assets | ||||||
1,859 | 691 | |||||
Accounts payable and accrued liabilities | ||||||
736 | 1,437 | |||||
Deferred revenue | ||||||
4,000 | 0 | |||||
Deferred rent | ||||||
-1,256 | -38 | |||||
Net cash used in operating activities | ||||||
-35,474 | -32,953 | |||||
Investing activities | ||||||
Proceeds from sale of equipment | ||||||
45 | 0 | |||||
Purchase of property and equipment | ||||||
888 | 3,500 | |||||
Net cash used in investing activities | ||||||
-843 | -3,500 | |||||
Financing activities | ||||||
Proceeds from initial public offering | ||||||
34,721 | 0 | |||||
Proceeds from public offering, net of issuance costs | ||||||
802 | 266 | |||||
Proceeds from the sale of convertible preferred stock, net of issuance costs | ||||||
14,379 | 52,468 | |||||
Net cash provided by financing activities | ||||||
49,902 | 52,734 | |||||
Net increase (decrease) in cash and cash equivalents | ||||||
13,585 | 16,281 | |||||
Supplemental disclosures of cash flow information: | ||||||
Cash paid for income taxes | ||||||
660 | 0 | |||||
Supplemental disclosures of non-cash investing and financing information | ||||||
Property and equipment purchases included in accounts payable | ||||||
0 | 753 | |||||
Convertible preferred stock converted to common stock | ||||||
175,490 | 0 | |||||
Forgiveness of promissory notes from related party for purchase of common stock | ||||||
397 | - | |||||